KiOmed Pharma news

Founded in 2014, KiOmed Pharma is a spin-off of KitoZyme. As explained by François Blondel, Founder and Executive Chairman of the Board of Directors, and Houtai Choumane, CEO of KiOmed Pharma, its aim is to offer solutions to cellular ageing using innovation based on mushrooms.

How does your innovation provide a solution for the healthcare sector? 

François Blondel: ‘We work in three

Belgian biotech company KiOmed Pharma has announced that it has entered into a worldwide (excluding USA) License and Supply Agreement with Sinclair Pharma, a global aesthetics company wholly owned by Huadong Medicine Company (HMC) Limited. Under the terms of the agreement, KiOmed will develop and supply Sinclair with a brand of innovative KiOmedine®-based products for the fast-growing multibillion-dollar aesthetics markets.

As part of the agreemen

Belgian biotech company KiOmed Pharma and digital therapeutics company moveUP are pleased to announce the signature of an exclusive agreement for the development and licensing of a unique mobile health companion application dedicated to personalised conservative intra-articular treatment for patients suffering from osteoarthritis. This application is to be developed by moveUP, while exclusive global marketing rights are to be granted to KiOmed, who will market it alongside their innovative si

KiOmed Pharma, an innovative Belgian biotech company, has reported positive safety and efficacy outcomes following the treatment of nearly 80 patients suffering from Knee OsteoArthritis (OA). This European Healthcare Professional (HCP) survey yielded a global long-term improvement of OA symptoms and shows preliminary evidence of improved outcomes in patients with advanced stage OA.

‘This HCP survey took place in a real-life clinical setting between three European countries a

KiOmed Pharma announces the appointment of two seasoned biotech executives: Dr Pierre Rigaux, MD, PhD is joining its Board of Directors, and Dr Mathias Schifflers, MD is appointed Chief Medical Officer and joins its executive management team

“We are absolutely delighted to announce the appointment of Dr Pierre Rigaux to our Board of Directors. Pierre is an extremely well-regarded executive and has a tremen